Trade Summary

6 days ago, Treace John T., serving as Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), purchased 55,944 shares at $4.41 per share, for a total transaction value of $246,654.31. Following this transaction, Treace John T. now holds 7,404,383 shares of TMCI.

This purchase represents a 0.76% increase in Treace John T.'s stake in the company.

The trade was executed on Thursday, August 20, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 24, 2026 at 5:00 PM ET, 4 days after the trade was made.

TREACE MEDICAL CONCEPTS, INC. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.